DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Rubie H, Chisholm J, Defachelles AS. et al.
Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Societe Francaise des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study.
J Clin Oncol 2006;
24: 5259-5264
We do not assume any responsibility for the contents of the web pages of other providers.